arrow_back Back to App

Smoking Cessation Support: Free Services and Medications in Medicaid and CHIP

This act aims to improve access to smoking cessation services and medications for individuals covered by Medicaid and CHIP. This means citizens using these programs will receive comprehensive support without additional costs, potentially improving their health and reducing financial burdens related to tobacco-related illnesses.
Key points
Free Smoking Cessation Services and Medications: Medicaid and CHIP will cover the costs of therapy and medications, including over-the-counter options, without additional patient charges.
No Prior Authorization Required: Prior approval will not be needed for smoking cessation medications, speeding up access to treatment.
Awareness Campaigns: States will conduct campaigns to increase awareness of available services and their benefits among patients and clinicians.
Financial Support for States: The federal government will cover 100% of the costs for these services and campaigns for two years after the COVID-19 emergency period ends, then revert to the standard percentage.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_2125
Sponsor: Rep. Blunt Rochester, Lisa [D-DE-At Large]
Process start date: 2021-03-23
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Quit Because of COVID–19 Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_2125.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-03-23.

What are the main provisions?

Key points include:

  • Free Smoking Cessation Services and Medications: Medicaid and CHIP will cover the costs of therapy and medications, including over-the-counter options, without additional patient charges.
  • No Prior Authorization Required: Prior approval will not be needed for smoking cessation medications, speeding up access to treatment.
  • Awareness Campaigns: States will conduct campaigns to increase awareness of available services and their benefits among patients and clinicians.
  • Financial Support for States: The federal government will cover 100% of the costs for these services and campaigns for two years after the COVID-19 emergency period ends, then revert to the standard percentage.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Blunt Rochester, Lisa [D-DE-At Large].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health Benefits